Clinical trial

Open Label Trial to Assess Iressa in Prostate Cancer Patients

NCT00635856

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-05-01

PhasePHASE2

Study timeline

Study start (unknown)2001-05-01Date precision: month

Registry last updated2009-04-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Interventions

GefitinibDRUG · verified · RxNorm: gefitinib

Sponsors & collaborators

AstraZenecalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00635856 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.